Journal article
Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators
JAMA : the journal of the American Medical Association, Vol.279(16), pp.1265-1272
04/01/1998
DOI: 10.1001/jama.279.16.1265
PMID: 9565006
Abstract
CONTEXT Anticoagulation with unfractionated heparin is used commonly for treatment of acute ischemic stroke, but its use remains controversial because it has not been shown to be effective or safe. Low molecular weight heparins and heparinoids have been shown to be effective in preventing deep vein thrombosis in persons with stroke, and they might be effective in reducing unfavorable outcomes following ischemic stroke.
Details
- Title: Subtitle
- Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators
- Creators
- Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators
- Contributors
- Harold P Adams Jr (Contributor) - University of Iowa, Neurology
- Resource Type
- Journal article
- Publication Details
- JAMA : the journal of the American Medical Association, Vol.279(16), pp.1265-1272
- DOI
- 10.1001/jama.279.16.1265
- PMID
- 9565006
- NLM abbreviation
- JAMA
- ISSN
- 0098-7484
- eISSN
- 1538-3598
- Language
- English
- Date published
- 04/01/1998
- Academic Unit
- Neurology; Iowa Neuroscience Institute
- Record Identifier
- 9984020744802771
Metrics
18 Record Views